NFKBIE突变由肿瘤微环境选择并促进慢性淋巴细胞白血病的免疫逃逸
该研究利用体外和体内小鼠模型及原发患者样本,发现NFKBIE突变的慢性淋巴细胞白血病(CLL)细胞被激活NF-κB通路的微环境信号选择,并诱导微环境改变导致免疫逃逸,包括CD8+ T细胞耗竭表型扩增和恶性B细胞PD-L1表达增加。NFKBIE突变小鼠CLL细胞对依鲁替尼显示选择性耐药,NFKBIE突变CLL患者接受依鲁替尼治疗结局较差。
要点
- NFKBIE突变CLL细胞被激活NF-κB的微环境信号选择。
- NFKBIE突变CLL中CD8+ T细胞耗竭表型扩增、恶性B细胞PD-L1表达增加。
- NFKBIE突变CLL对依鲁替尼耐药且治疗结局较差。
核心结论
- NFKBIE突变可通过与微环境双向交互及降低BTK抑制剂敏感性等多种机制促进CLL进展。
研究设计与样本
- 研究使用体外和体内小鼠模型及原发患者样本。
主要发现
- NFKBIE突变的CLL细胞被激活NF-κB通路的微环境信号选择。
- NFKBIE突变CLL中CD8+ T细胞耗竭表型扩增,恶性B细胞PD-L1表达增加。
- NFKBIE突变CLL患者T细胞耗竭标志物表达增加。
- NFKBIE突变小鼠CLL细胞对依鲁替尼显示选择性耐药。
- NFKBIE突变CLL患者接受依鲁替尼治疗结局较差。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Loss-of-function mutations in NFKBIE, which encodes for the NF-κB inhibitor IκBε, are frequent in chronic lymphocytic leukemia (CLL) and certain other B-cell malignancies and have been associated with accelerated disease progression and inferior responses to chemotherapy. Using in vitro and in vivo murine models and primary patient samples, we now show that NFKBIE-mutated CLL cells are selected by microenvironmental signals that activate the NF-κB pathway and induce alterations within the tumor microenvironment that can allow for immune escape, including expansion of CD8+ T-cells with an exhausted phenotype and increased PD-L1 expression on the malignant B-cells. Consistent with the latter observations, we find increased expression of exhaustion markers on T-cells from patients with NFKBIE-mutated CLL. In addition, we show that NFKBIE-mutated murine CLL cells display selective resistance to ibrutinib and report inferior outcomes to ibrutinib treatment in NFKBIE-mutated CLL patients. These findings suggest that NFKBIE mutations can contribute to CLL progression through multiple mechanisms, including a bidirectional crosstalk with the microenvironment and reduced sensitivity to BTK inhibitor treatment.
引用
- Bonato A, Chakraborty S, Bomben R, et al. NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia. Leukemia. 2024. PMID: 38486128. doi:10.1038/s41375-024-02224-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。